Parvovirus B19 vaccine (National Institutes of Health/Meridian Bioscience)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameParvovirus B19 vaccine (National Institutes of Health/Meridian Bioscience)

Drug Alias Name细小病毒B19疫苗 - 美国国立卫生研究院/Meridian BioscienceVAIVP-705

ClassificationVaccines > Development/production technology > Genetically engineered subunit vaccineVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsParvoviridae Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesNational Institute of Health, Islamabad

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesNational Institutes Of Health Meridian Bioscience

Active IndicationsN/A

Inactive IndicationsParvoviridae Infections

Other Information

ATC CodeN/A